Generate Biomedicines
GENB
#5164
Rank
A$2.54 B
Marketcap
A$19.84
Share price
-0.50%
Change (1 day)
N/A
Change (1 year)

Generate Biomedicines (GENB) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$0.15 Billion

According to Generate Biomedicines's latest financial reports the company's total liabilities are A$0.15 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Generate Biomedicines - Total liabilities on balance sheet (from 2026 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$1.42 B-7.13%
2024-12-31A$1.53 B